Currently in research and development are several small molecule nonpeptide oral GLP-1 agonists that have positive human research results
Quick Takeaways Tesamorelin has robust clinical evidence for reducing visceral fat (15-17.5%), increasing lean mass (1.42 kg), and improving metabolic markers in human trials Ipamorelin selectively releases growth hormone without affecting cortisol or prolactin, making it the cleanest GHRP available Combining a GHRH with a GHRP creates synergistic GH pulsatility that mimics and amplifies your bodys natural growth hormone patterns My recommended protocol: Tesamorelin 1mg + Ipamorelin 100mcg, injected AM/PM, 5 days on/2 days off, 8 weeks on/8 weeks off What This Peptide Combination Actually Is Tesamorelin and Ipamorelin target different receptors in the growth hormone regulation system, which is precisely why they work so well together
If you want to understand appetite suppression timelines in more detail, our guide on how long it takes tirzepatide to suppress appetite covers the mechanism regardless of administration route
full agonist at all three at cAMP signaling (E_max numbers in ref )
Conclusions Our real-world data confirms that FILGO is safe and effective for patients with UC
Andrew Huberman: There's this beautiful study out this last year where, this took place over in Israel, where they had people get outside for 20 or 30 minutes a day, three times a week, exposing a culturally acceptable yet substantial amount of their skin during that time and saw big increases in testosterone and estrogen
